U.S. Congress - S.3187 Synthetic Drug Abuse Prevention Act of 2012
S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)
All Bill Titles
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
- Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
- Short: Medical Device User Fee Amendments of 2012 as passed senate.
- Short: Generic Drug User Fee Amendments of 2012 as passed senate.
- Short: Biosimilar User Fee Act of 2012 as passed senate.
- Short: Food and Drug Administration Safety and Innovation Act as passed senate.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Safety and Innovation Act as passed house.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as enacted.
- Short: Biosimilar User Fee Act of 2012 as enacted.
- Short: Generic Drug User Fee Amendments of 2012 as enacted.
- Short: Medical Device User Fee Amendments of 2012 as enacted.
- Short: Prescription Drug User Fee Amendments of 2012 as enacted.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
All Votes
Roll call number 168 in the Senate
Question: On the Motion (Motion to Concur in the House Amendment to Accompany S. 3187)
Roll call number 166 in the Senate
Question: On the Cloture Motion S. 3187
Roll call number 111 in the Senate
Question: On Passage of the Bill S. 3187
Roll call number 110 (Amendment number S.Amdt.2127) in the Senate
Question: On the Motion to Table S.Amdt. 2127 to S. 3187 (No short title on file)
Amendment purpose: To require manufacturers of dietary supplements to register dietary supplement products with the Food and Drug Administration.
Roll call number 109 (Amendment number S.Amdt.2109) in the Senate
Question: On the Amendment S.Amdt. 2109 to S. 3187 (No short title on file)
Amendment purpose: To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws.
Roll call number 108 (Amendment number S.Amdt.2107) in the Senate
Question: On the Amendment S.Amdt. 2107 to S. 3187 (No short title on file)
Amendment purpose: To allow the importation by individuals of safe and affordable drugs from Canada.
Roll call number 107 (Amendment number S.Amdt.2143) in the Senate
Question: On the Motion to Table S.Amdt. 2143 to S. 3187 (No short title on file)
Amendment purpose: To amend the Federal Food, Drug, and Cosmetic Act concerning claims about the effects of foods and dietary supplements on health-related conditions and disease, to prohibit employees of the Food and Drug Administration from carrying firearms and making arrests without warrants, and to adjust the mens rea of certain prohibited acts under the Federal Food, Drug, and Cosmetic Act to knowing and willful.
Roll call number 106 (Amendment number S.Amdt.2108) in the Senate
Question: On the Amendment S.Amdt. 2108 to S. 3187 (No short title on file)
Amendment purpose: To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval.
Vote on This Bill
-
Share This Bill
More Share via Email
